Intake and circulating concentrations of antioxidants in metabolic syndrome

Current Atherosclerosis Reports

Volumn 8, Issue 6, 2006, Pages 448-452

  Ford, Earl S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; CRYPTOXANTHIN; DELTA TOCOPHEROL; FLAVONOID; GAMMA TOCOPHEROL; LYCOPENE; POLYPHENOL; RETINOL; SELENIUM; XANTHOPHYLL; ZEAXANTHIN;

BLOOD LEVEL; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DIETARY INTAKE; ENDOTHELIAL DYSFUNCTION; FOOD INTAKE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MEDITERRANEAN DIET; METABOLIC SYNDROME X; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; RISK FACTOR;

ANTIOXIDANTS; BIOLOGICAL MARKERS; HUMANS; METABOLIC SYNDROME X; OXIDATIVE STRESS;

EID: 33750686614     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-006-0018-8     Document Type: Review

References (57)

1. Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005, 28:2745-2749.
2. Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005, 28:1769-1778.
3. Lee KU: Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract 2001, 54(Suppl 2):S29-S33.
4. Griendling KK, FitzGerald GA: Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 2003, 108:2034-2040.
5. Stephens JW, Gable DR, Hurel SJ, et al.: Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males. Clin Chem 2006, 52:446-452.
6. Knekt P, Ritz J, Pereira MA, et al.: Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 2004, 80:1508-1520.
7. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405-412.
8. Ford ES, Will JC, Bowman BA, Narayan KM: Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 1999, 149:168-176.
9. Salonen JT, Nyyssonen K, Tuomainen TP, et al.: Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. BMJ 1995, 311:1124-1127.
10. Knekt P, Reunanen A, Marniemi J, et al.: Low vitamin E status is a potential risk factor for insulin-dependent diabetes mellitus. J Intern Med 1999, 245:99-102.
11. Mayer-Davis EJ, Costacou T, King I, et al.: Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS). Diabetes Care 2002, 25:2172-2177.
12. Hozawa A, Jacobs DR Jr, Steffes MW, et al.: Associations of Serum Carotenoid Concentrations with the Development of Diabetes and with Insulin Concentration: Interaction with Smoking: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 2006, 163:929-937.
13. Montonen J, Knekt P, Jarvinen R, Reunanen A: Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 2004, 27:362-366.
14. Liu S, Ajani U, Chae C, et al.: Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial. JAMA 1999, 282:1073-1075.
15. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al.: Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J 2004, 147:106-112.
16. Pitsavos C, Panagiotakos DB, Chrysohoou C, et al.: The adoption of Mediterranean diet attenuates the development of acute coronary syndromes in people with the metabolic syndrome. Nutr J 2003, 2:1.
17. Esposito K, Marfella R, Ciotola M, et al.: Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292:1440-1446.
18. Ford ES, Mokdad AH, Giles WH, Brown DW: The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003, 52:2346-2352.
19. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
20. Evans JL, Maddux BA, Goldfine ID: The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005, 7:1040-1052.
21. Facchini FS, Humphreys MH, DoNascimento CA, et al.: Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols. Am J Clin Nutr 2000, 72:776-779.
22. Ylonen K, Alfthan G, Groop L, et al.: Dietary intakes and plasma concentrations of carotenoids and tocopherols in relation to glucose metabolism in subjects at high risk of type 2 diabetes: the Botnia Dietary Study. Am J Clin Nutr 2003, 77:1434-1441.
23. Coyne T, Ibiebele TI, Baade PD, et al.: Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland, Australia. Am J Clin Nutr 2005, 82:685-693.
24. Ford ES, Mokdad AH, Ajani UA, Liu S: Associations between concentrations of alpha- and gamma-tocopherol and concentrations of glucose, glycosylated haemoglobin, insulin and C-peptide among US adults. Br J Nutr 2005, 93:249-255.
25. Sugiura M, Nakamura M, Ikoma Y, et al.: The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects. J Epidemiol 2006, 16:71-78.
26. Paolisso G, D'Amore A, Giugliano D, et al.: Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993, 57:650-656.
27. Paolisso G, D'Amore A, Galzerano D, et al.: Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care 1993, 16:1433-1437.
28. Paolisso G, Di Maro G, Galzerano D, et al.: Pharmacological doses of vitamin E and insulin action in elderly subjects. Am J Clin Nutr 1994, 59:1291-1296.
29. Skrha J, Sindelka G, Kvasnicka J, Hilgertova J: Insulin action and fibrinolysis influenced by vitamin E in obese Type 2 diabetes mellitus. Diabetes Res Clin Pract 1999, 44:27-33.
30. Manning PJ, Sutherland WH, Walker RJ, et al.: Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes Care 2004, 27:2166-2171.
31. McSorley PT, Bell PM, Young IS, et al.: Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial. Diabet Med 2005, 22:703-710.
32. Johnston CS, Yen MF: Megadose of vitamin C delays insulin response to a glucose challenge in normoglycemic adults. Am J Clin Nutr 1994, 60:735-738.
33. Paolisso G, Balbi V, Volpe C, et al.: Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J Am Coll Nutr 1995, 14:387-392.
34. Chen H, Karne RJ, Hall G, et al.: High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol 2006, 290:H137-145.
35. Fornoni A, Raij L: Metabolic syndrome and endothelial dysfunction. Curr Hypertens Rep 2005, 7:88-95.
36. Duvall WL: Endothelial dysfunction and antioxidants. Mt Sinai J Med 2005, 72:71-80.
37. Sola S, Mir MQ, Cheema FA, et al.: Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation 2005, 111:343-348.
38. Ford ES: The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003, 168:351-358.
39. Cannon JG, Meydani SN, Fielding RA, et al.: Acute phase response in exercise. II. Associations between vitamin E, cytokines, and muscle proteolysis. Am J Physiol 1991, 260(6 Pt 2):R1235-1240.
40. Devaraj S, Jialal I: Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med 2000, 29:790-792.
41. Murphy RT, Foley JB, Tome MT, et al.: Vitamin E modulation of C-reactive protein in smokers with acute coronary syndromes. Free Radic Biol Med 2004, 36:959-965.
42. Wu D, Han SN, Meydani M, Meydani SN: Effect of concomitant consumption of fish oil and vitamin E on production of inflammatory cytokines in healthy elderly humans. Ann N Y Acad Sci 2004, 1031:422-424.
43. Kaul N, Devaraj S, Grundy SM, Jialal I: Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/ day) in normal subjects. Am J Cardiol 2001, 87:1320-1323.
44. Vega-Lopez S, Kaul N, Devaraj S, et al.: Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism 2004, 53:236-240.
45. Carr BR, Khan N, Adams-Huet B, et al.: Effect of vitamin E supplementation with and without hormone therapy on circulatory inflammatory markers in postmenopausal women. Fertil Steril 2006, 85:667-673.
46. Block G, Jensen C, Dietrich M, et al.: Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation. J Am Coll Nutr 2004, 23:141-147.
47. Tousoulis D, Antoniades C, Tentolouris C, et al.: Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers. Atherosclerosis 2003, 170:261-267.
48. Scott DA, Poston RN, Wilson RF, et al.: The influence of vitamin C on systemic markers of endothelial and inflammatory cell activation in smokers and non-smokers. Inflamm Res 2005, 54:138-144.
49. Fumeron C, Nguyen-Khoa T, Saltiel C, et al.: Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrol Dial Transplant 2005, 20:1874-1879.
50. Carroll MF, Schade DS: Tuning of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers. Circulation 2003, 108:24-31.
51. Engler MM, Engler MB, Malloy MJ, et al.: Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation 2003, 108:1059-1063.
52. Phillips T, Childs AC, Dreon DM, et al.: A dietary supplement attenuates IL-6 and CRP after eccentric exercise in untrained males. Med Sci Sports Exerc 2003, 35:2032-2037.
53. Accinni R, Rosina M, Bamonti F, et al.: Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. Nutr Metab Cardiovasc Dis 2006, 16:121-127.
54. Mastaloudis A, Morrow JD, Hopkins DW, et al.: Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners. Free Radic Biol Med 2004, 36:1329-1341.
55. Watzl B, Kulling SE, Moseneder J, et al.: A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. Am J Clin Nutr 2005, 82:1052-1058.
56. de Maat MP, Pijl H, Kluft C, Princen HM: Consumption of black and green tea had no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals. Eur J Clin Nutr 2000, 54:757-763.
57. Riso P, Visioli F, Grande S, et al.: Effect of a tomato-based drink on markers of inflammation, immunomodulation, and oxidative stress. J Agric Food Chem 2006, 54:2563-2566.